New research from Stockholm University and Karolinska Institutet shows that viruses interact with proteins in the biological fluids of their host which results in a layer of proteins on the viral surface. This coat of proteins makes the virus more infectious and facilitates the formation of plaques characteristic of neurodegenerative diseases such as Alzheimer’s disease.
Are viruses dead or alive? Well… both. Viruses can only reproduce inside living cells and exploit the cellular machinery of their host to their benefit. However, before entering a host cell, viruses are just nanometer-sized particles, very similar to artificial nanoparticles used in medical applications for diagnosis and therapy. Scientists from Stockholm University and Karolinska Institutet have found that viruses and nanoparticles share another important property; they both become covered by a layer of proteins when they encounter the biological fluids of their host before they find their target cell. This layer of proteins on the surface influence their biological activity significantly.
“Imagine a tennis ball falling into a bowl of milk and cereals. The ball is immediately covered by the sticky particles in the mix and they remain on the ball when you take it out of the bowl. The same thing happens when a virus gets in contact with blood or lung fluids that contain thousands of proteins. Many of these proteins immediately stick to the viral surface forming a so-called protein corona”, Kariem Ezzat of Stockholm University and Karolinska Institutet explains.
Kariem Ezzat and his colleagues studied the protein corona of respiratory syncytial virus (RSV) in different biological fluids. RSV is the most common cause of acute lower respiratory tract infections in young children worldwide, leading up to 34 million cases and 196,000 fatalities each year. “The protein corona signature of RSV in the blood is very different from that in lung fluids. It is also different between humans and other species such as rhesus macaque monkeys, which also can be infected with RSV”, Kariem Ezzat says. “The virus remains unchanged on the genetic level. It just acquires different identities by accumulating different protein coronae on its surface depending on its environment. This makes it possible for the virus to use extracellular host factors for its benefit, and we’ve shown that many of these different coronae make RSV more infectious.”
The researchers from Stockholm University and Karolinska Institutet have also found that viruses such as RSV and herpes simplex virus type 1 (HSV-1) can bind a special class of proteins called amyloid proteins. Amyloid proteins aggregate into plaques that play a part in Alzheimer’s disease where they lead to neuronal cell death. The mechanism behind the connection between viruses and amyloid plaques has been hard to find till now, but Kariem Ezzat and his colleagues found that HSV-1 is able to accelerate the transformation of soluble amyloid proteins into thread-like structures that constitute the amyloid plaques. In animal models of Alzheimer’s disease, they saw that mice developed the disease within 48 hours of infection in the brain. In absence of an HSV-1 infection the process normally takes several months.
“The novel mechanisms described in our paper can have an impact not only on understanding new factors determining how infectious a virus is, but also on devising new ways to design vaccines. In addition, describing a physical mechanism that links viral and amyloid causes of disease adds weight to the increasing research interest in the role of microbes in neurodegenerative disorders such as Alzheimer’s disease and opens up new avenues for treatments.”, Kariem Ezzat of Stockholm University and Karolinska Institutet says.
Learn more: Coat of proteins makes viruses more infectious and links them to Alzheimer’s disease
The Latest on: Neurodegenerative diseases
[google_news title=”” keyword=”neurodegenerative diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Neurodegenerative diseases
- Empty-handed neurons might cause neurodegenerative diseaseson April 19, 2024 at 10:33 pm
Researchers from Tokyo Metropolitan University have identified how proteins collect abnormally in neurons, a feature of neurodegenerative diseases like Alzheimer’s. They used fruit flies to show that ...
- Chronic wasting disease: Death of 2 hunters in US raises fear of 'zombie deer'on April 19, 2024 at 3:39 pm
The 2022 deaths of two hunters who ate venison infected with chronic wasting disease (CWD) has raised concerns the illness could pass to humans.
- Battle against fatal neurodegenerative disease advances on two frontson April 19, 2024 at 11:13 am
Given no more than five years to live, Blais set about ticking off his final bucket-list challenge: the annual "Ironman World Championship" in the US state of Hawaii. In October 2005, six months after ...
- Researchers set new standards for nanoparticles, helping patients with MS, ALS, Parkinson's diseaseon April 19, 2024 at 9:31 am
Is it possible for nanoparticles to go through the digestive system and deliver medicine directly to the brain tissue? Researchers from Michigan State University say yes, and their latest findings are ...
- Study Links Recreational Cannabis Use to Lower Risk of Cognitive Decline and Dementia-Related Diseaseson April 19, 2024 at 4:01 am
The effect was seen with recreational-use cannabis, or cannabis cultivated not to maximize the plant's production of CBD, but to maximize THC ...
- Research Links Parkinson’s and Lewy Body Disease with Chemical Effects on Brain and Guton April 18, 2024 at 9:01 pm
Parkinson’s disease (PD) and certain forms of dementia have been associated with exposure to pesticides, industrial chemicals, and air pollution for decades. But the mechanisms of disease progression ...
- Nanoparticles may enable direct medicine delivery to brain in neurodegenerative disorderson April 18, 2024 at 5:00 pm
Researchers from Michigan State University say yes, and their latest findings are expected to benefit patients with neurodegenerative disorders like multiple sclerosis, or MS; amyotrophic lateral ...
- Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseaseson April 18, 2024 at 12:46 pm
Cardiovascular diseases, including stroke and myocardial infarction, are the world's leading causes of mortality, accounting for over 18 million deaths a year.
- Parkinson’s Disease Drug Tavapadon Significantly Improved Symptom Control, Cerevel Sayson April 18, 2024 at 7:37 am
A late-stage trial of Cerevel Therapeutic’s Parkinson’s disease drug showed a significant reduction in the time patients suffer from symptoms, the company said Thursday, the latest study indicating ...
- Medical Monday: Therapy Options for Those with Parkinson’s Diseaseon April 16, 2024 at 10:09 am
In this week's Medical Monday, we focus on some of the therapy options available for those who suffer from Parkinson's Disease.
via Bing News